Ibio Reports Fiscal First Quarter 2025 Financial Results
(MENAFN- GlobeNewsWire - Nasdaq) Advanced myostatin program with dosing underway in non-human primate study SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) today reported financial results for the fiscal first quarter ended September …